|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703
|
|
G |
Lrrk2em1Sage |
leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
|
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
IMP |
|
RGD |
PMID:30249809 |
RGD:41404725 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf1rtm(EGFP)Tset |
colony stimulating factor 1 receptor; target mutant, Tset |
|
IMP |
|
RGD |
PMID:30249809 |
RGD:41404725 |
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703
|
|
G |
Lrrk2em1Sage |
leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
|
IMP |
in male |
RGD |
PMID:31125290 |
RGD:14696717 |
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Htr7em1Msu |
5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu |
|
IMP |
in male |
RGD |
PMID:31125290 |
RGD:14696717 |
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703
|
|
G |
Rarres2 |
retinoic acid receptor responder 2 |
sexual_dimorphism |
IMP |
compared to male wild-type |
RGD |
PMID:29906243 PMID:29906243 |
RGD:38596340, RGD:38596340 |
NCBI chr 4:77,522,549...77,525,733
Ensembl chr 4:77,522,535...77,525,556
|
|
G |
Rarres2em1Msu |
retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu |
sexual_dimorphism |
IMP |
compared to male wild-type |
RGD |
PMID:29906243 PMID:29906243 |
RGD:38596340, RGD:38596340 |
|
|
|
G |
Il1rl2 |
interleukin 1 receptor-like 2 |
|
IMP |
compared to Wild Type in cardiopulmonary bypass model |
RGD |
PMID:32048631 |
RGD:126925167 |
NCBI chr 9:42,591,658...42,639,351
Ensembl chr 9:42,591,934...42,636,667
|
|
G |
Il1rl2tm1(Myh6-cre)Mhzh |
interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh |
|
IMP |
compared to Wild Type in cardiopulmonary bypass model |
RGD |
PMID:32048631 |
RGD:126925167 |
|
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
IMP |
compared to wild type |
RGD |
PMID:26077568 |
RGD:13800514 |
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd11b2em1Jmul |
hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul |
|
IMP |
compared to wild type |
RGD |
PMID:26077568 |
RGD:13800514 |
|
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
IAGP |
compared to LEA/Hok |
RGD |
PMID:30733544 PMID:17303181 |
RGD:25823141, RGD:2292672 |
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Atp7bhts |
ATPase copper transporting beta; hepatitis |
|
IAGP |
compared to LEA/Hok |
RGD |
PMID:17303181 PMID:30733544 |
RGD:2292672, RGD:25823141 |
|
|
G |
Lepr |
leptin receptor |
|
IMP IAGP |
|
RGD |
PMID:27225180 PMID:23154293 |
RGD:12910507, RGD:13432147 |
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Leprem3 |
leptin receptor; TALEN induced mutant 3 |
|
IMP |
|
RGD |
PMID:27225180 |
RGD:12910507 |
|
|
G |
Leprfa |
leptin receptor; fa mutant |
|
IAGP |
|
RGD |
PMID:23154293 |
RGD:13432147 |
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
|
IMP |
|
RGD |
PMID:19155635 |
RGD:2316657 |
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
|
|
G |
Ren |
renin |
|
IMP |
compared to wild type |
RGD |
PMID:21242461 |
RGD:7771614 |
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Renem1Mcwi |
renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin |
|
IMP |
compared to wild type |
RGD |
PMID:21242461 |
RGD:7771614 |
|
|
|
G |
Gla |
galactosidase, alpha |
onset |
IMP |
compared to Wild type |
RGD |
PMID:29979634 |
RGD:401976416 |
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
onset |
IMP |
compared to Wild type |
RGD |
PMID:29979634 |
RGD:401976416 |
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:28124283 |
RGD:13703118 |
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
|
|
G |
Lamp2em1 |
lysosomal-associated membrane protein 2; TALEN induced mutant1 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:28124283 |
RGD:13703118 |
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
|
IMP |
|
RGD |
PMID:19155635 |
RGD:2316657 |
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
sexual_dimorphism |
IMP |
females compared to Hsd:SD females |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
sexual_dimorphism |
IMP |
females compared to Hsd:SD females |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
IAGP |
compared to LEA/Hok |
RGD |
PMID:30733544 |
RGD:25823141 |
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Atp7bhts |
ATPase copper transporting beta; hepatitis |
|
IAGP |
compared to LEA/Hok |
RGD |
PMID:30733544 |
RGD:25823141 |
|
|
G |
Gla |
galactosidase, alpha |
onset |
IMP |
compared to Wild type |
RGD |
PMID:29979634 |
RGD:401976416 |
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
onset |
IMP |
compared to Wild type |
RGD |
PMID:29979634 |
RGD:401976416 |
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
|
IMP |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:28124283 |
RGD:13703118 |
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
|
|
G |
Lamp2em1 |
lysosomal-associated membrane protein 2; TALEN induced mutant1 |
|
IMP |
|
RGD |
PMID:28124283 |
RGD:13703118 |
|
|
G |
Lepr |
leptin receptor |
|
IMP |
|
RGD |
PMID:27225180 |
RGD:12910507 |
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Leprem3 |
leptin receptor; TALEN induced mutant 3 |
|
IMP |
|
RGD |
PMID:27225180 |
RGD:12910507 |
|
|
|
G |
Dmd |
dystrophin |
|
IMP |
|
RGD |
PMID:25310701 |
RGD:12880034 |
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
|
|
G |
Dmdem1Ang |
dystrophin; TALEN-induced mutant1, Ang |
|
IMP |
|
RGD |
PMID:25310701 |
RGD:12880034 |
|
|
|
G |
Il36rn |
interleukin 36 receptor antagonist |
|
IMP |
|
RGD |
PMID:32048631 |
RGD:126925167 |
NCBI chr 3:7,044,419...7,051,016
Ensembl chr 3:7,044,406...7,051,016
|
|
G |
Il36rntm1(Myh6-cre)Mhzh |
interleukin 36 receptor antagonist; tm1, Mhzh |
|
IMP |
|
RGD |
PMID:32048631 |
RGD:126925167 |
|
|